Evidence map›Paper›PMID 41890615›Full record

ArticleArXiv2026

UNSUPERVISED ADAPTATION FROM FDG TO PSMA PET/CT FOR 3D LESION DETECTION UNDER LABEL SHIFT.

Xiaofeng Liu, Menghua Xia, Yanis Chemli, Georges El Fakhri, Chi Liu, Jinsong Ouyang

Abstract readPreprint
In one paragraph

Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaofeng LiuYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.
Menghua XiaYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.
Yanis ChemliYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.
Georges El FakhriYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.
Chi LiuYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.
Jinsong OuyangYale Biomedical Imaging Institute and Department of Radiology & Biomedical Imaging, Yale University, New Haven, CT 06520, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we propose an unsupervised domain adaptation (UDA) framework for 3D volumetric lesion detection that adapts a detector trained on labeled FDG PET/CT to unlabeled PSMA PET/CT. Beyond covariate shift, cross tracer adaptation also exhibits label shift in both lesion size composition and the number of lesions per subject. We introduce self-training with two mechanisms that explicitly model and compensate for this label shift. First, we adaptively adjust the detection anchor shapes by re-estimating target domain box scales from selected pseudo labels and updating anchors with an exponential moving average. This increases positive anchor coverage for small PSMA lesions and stabilizes box regression. Second, instead of a fixed confidence threshold for pseudo-label selection, we allocate size bin-wise quotas according to the estimated target domain histogram over lesion volumes. The self-training alternates between supervised learning with prior-guided pseudo labeling on PSMA and supervised learning on labeled FDG. On AutoPET 2024, adapting from 501 labeled FDG studies to 369

Indexed as

Label ShiftLesion DetectionPET/CTSelf-trainingUnsupervised Domain Adaptation

Identifiers

PMID41890615
PMCPMC13014160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.